Ms. Elkins, co-founder of the EGFR Resisters advocacy group, will be remembered for her warm and energetic approach to furthering lung cancer research efforts. Read more
The IASLC’s official journal now ranks second among 100 respiratory medicine journals and 13th among 322 oncology journals. Read more
Submit abstracts for ACLC 2024 by June 7, register for the 2024 CT Screening Symposium, and contribute memories for the 50th anniversary time capsule. Read more
The association seeks input from members to better understand the current DEI landscape so it can continue to build a diverse international community dedicated to the elimination of thoracic malignancies. Read more
Lung Cancer 360 offers a centralized hub for thoracic oncology learning opportunities spanning multiple disciplines and formats. Read more
Dr. Mark Kris, who leads the IASLC Pathologic Response Project, recently provided an update on efforts to collect data to confirm whether pathologic complete response can predict long-term outcomes. Read more
Get to know IASLC’s new Chief Science Officer and learn more about the role she and her team will play in conquering thoracic cancers in the 21st century. Read more
The IASLC seeks the lung cancer community’s input to assess the use of molecular testing—and barriers to its implementation—worldwide. Read more
Drs. Umberto Malapelle, Jarushka Naidoo, Isabelle Opitz, and Noemí Reguart will lead WCLC when it returns to Barcelona September 6-9, 2025. Read more
Projects—including a team science grant, an expanded IASLC Academy, and an international biomarker survey—aim to help the association meet the needs of the global lung cancer community, IASLC leaders say. Read more